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Abstract
P0-Cre and Wnt1-Cre mouse lines have been widely used in combination with loxP-flanked mice
to label and genetically modify neural crest (NC) cells and their derivatives. Wnt1-Cre has been
regarded as the gold standard and there have been concerns about the specificity of P0-Cre
because it is not clear about the timing and spatial distribution of the P0-Cre transgene in labeling
NC cells at early embryonic stages. We re-visited P0-Cre and Wnt1-Cre models in the labeling of
NC cells in early mouse embryos with a focus on cranial NC. We found that R26-lacZ Cre reporter
responded to Cre activity more reliably than CAAG-lacZ Cre reporter during early embryogenesis.
Cre immunosignals in P0-Cre and reporter (lacZ and RFP) activity in P0-Cre/R26-lacZ and P0-Cre/
R26-RFP embryos was detected in the cranial NC and notochord regions in E8.0–9.5 (4–19
somites) embryos. P0-Cre transgene expression was observed in migrating NC cells and was more
extensive in the forebrain and hindbrain but not apparent in the midbrain. Differences in the Cre
distribution patterns of P0-Cre andWnt1-Cre were profound in the midbrain and hindbrain regions,
that is, extensive in the midbrain of Wnt1-Cre and in the hindbrain of P0-Cre embryos. The differ-
ence between P0-Cre and Wnt1-Cre in labeling cranial NC may provide a better explanation of the
differential distributions of their NC derivatives and of the phenotypes caused by Cre-driven
genetic modifications.
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1 | INTRODUCTION
Neural crest (NC) is a multipotent cell population derived from the lat-
eral ridges of the neural plate in early vertebrate embryos (Leikola,
1976; Trainor, 2015). After delamination from the neural folds, NC cells
migrate ventrally and extensively, giving rise to a wide variety of differ-
entiated cell types, for example, neurons, glia, bone, cartilage, and con-
nective tissue of the head (Bronner-Fraser, 2004; Crane and Trainor,
2006; Meulemans and Bronner-Fraser, 2004; Munoz and Trainor,
2015; Trainor, 2005b). Labeling and tracking NC have been essential
for understanding the NC contribution to different tissue and cell
types, which is fundamental for organogenesis.
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Recently, cell lineage tracing using NC-specific promoter driven
Cre transgenic mouse lines in combination with Cre reporter mouse
lines has facilitated genetic marking of NC cells and their deriva-
tives. Multiple Cre transgenic mouse lines have been generated
using a NC marker gene promoter, for example, Wnt1-Cre (Echelard,
Vassileva, & McMahon, 1994; Jiang, Iseki, Maxson, Sucov, &
Morriss-Kay, 2002; McMahon, Joyner, Bradley, & McMahon, 1992),
P0-Cre (Wang, Komatsu, & Mishina, 2011; Yamauchi et al., 1999;
Zhang, Marsh, Ratner, & Brackenbury, 1995), Dhh-Cre (Gershon
et al., 2009; Wang, Kumar, Mitsios, Slevin, & Kumar, 2007), Pax3-
Cre (Jarad and Miner, 2009), HtPA-Cre (Lee et al., 2013), Sox10-Cre
(Simon, Lickert, Gotz, & Dimou, 2012), Mef2c-F10N-Cre (Aoto et al.,
2015). Use of these models has yielded new data pertaining to NC
cell specifications in mice, for example, distinct genesis of skin-
derived precursors in craniofacial and dorsal skin from NC and mes-
oderm, respectively (Jinno et al., 2010), NC and placodal derivation
of the otic vesicle (Freyer, Aggarwal, & Morrow, 2011), a dual origin
of sensory organs that include olfactory epithelium (Katoh et al.,
2011) and taste bud cells (Boggs et al., 2016; Liu, Komatsu, Mishina,
& Mistretta, 2012), and a dual origin of tooth bud epithelium (Wang
et al., 2011).
However, variations/discrepancies in the different models that
label NC cell lineage have been reported, such as in tooth (Wang et al.,
2011); olfactory epithelium (Suzuki, Yoshizaki, Kobayashi, & Osumi,
2013); heart (Cavanaugh, Huang, & Chen, 2015; Milgrom-Hoffman et
al., 2014; Nakamura, Colbert, & Robbins, 2006; Tomita et al., 2005),
and taste organs (Boggs et al., 2016; Liu et al., 2012). In comparative
studies on NC contributions to specific lineages, the Wnt1-Cre and P0-
Cre lines have been widely used (Katoh et al., 2011; Liu et al., 2012;
Morikawa et al., 2009; Nagoshi et al., 2008, Nagoshi et al., 2011;
Nakamura et al., 2006; Yoshida et al., 2006; Yoshida et al., 2008).
Wnt1-Cre has been regarded as the gold standard for NC lineage,
however, Wnt1-Cre also labels cells in the neural tube that makes
researchers question the specificity of this line and other models when
a difference is observed compared to Wnt1-Cre (Trainor, 2005a). In
fact, a difference between Wnt1-Cre and P0-Cre in labeling NC has
been found in multiple organs (Freem et al., 2010; Kawakami et al.,
2011; Lewis et al., 2013; Liu et al., 2012; Wang et al., 2011). In
contrast to Wnt1-Cre, which has been reported to trace NC cells as
early as E8.5 using a ROSA26 (hereafter, R26-lacZ) Cre reporter in mice
(Chai et al., 2000; Ikeya et al., 1997; Jiang et al., 2002; McMahon et al.,
1992), P0-Cre has been reported to label NC derivatives at stages later
than E9.0 using CAAG-CAT-lacZ (hereafter, CAAG-lacZ) as a reporter
system (Yamauchi et al., 1999). Although in situ hybridization for P0-
Cre transgene expression was performed (Yamauchi et al., 1999), there
is no detailed information available regarding the labeling of P0-Cre in
NC cells at early stages.
In the present study, the expression of two commonly used
reporter transgenes, CAAG-lacZ and R26-lacZ, were compared in early
embryos, and we found that DNA recombination was not consistent in
the CAAG-lacZ reporter when driven by Meox2-Cre in early embryos.
To further evaluate the timing, specificity and spatial distribution of P0-
Cre and Wnt1-Cre activity, we used the R26-lacZ and R26-tdTomato
(R26-RFP) reporters and carried out immunoreactions for Cre. Subse-
quently, we thoroughly compared the presence of Cre recombinase in
pre- and post-migratory NC cells in P0-Cre andWnt1-Cre embryos. Our
data indicate that the P0-Cre transgene expression is specifically dis-
tributed in migrating cranial NC in addition to the notochord, and Cre
immunosignals were especially extensive in the forebrain and hindbrain
regions. In contrast, Wnt1-Cre transgene expression was obvious in
forebrain and midbrain NC cells but was sparse in migrating NC in the
hindbrain regions.
2 | MATERIALS AND METHODS
2.1 | Animals
Animals were maintained and used in compliance with institutional ani-
mal care protocols of the University of Georgia, the University of Mich-
igan and the National Institute of Environmental Health, and in
accordance with the National Institutes of Health Guidelines for Care
and Use of Animals in research.
Mice carrying Cre recombinase driven by the protein zero (P0) pro-
moter (P0-Cre mouse, C57BL/6J-Tg(P0-Cre)94Imeg (ID 148)), were pro-
vided by CARD, Kumamoto University, Japan (Yamauchi et al., 1999)
and were mated with C57BL/6 wild type (WT) or Cre-reporter mice
R26-lacZ (Soriano, 1999) or ZEG (LacZ/EGFP) (Novak et al., 2000) or
R26-tdTomato (RFP) (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J, Jack-
son Lab, Stock #007914) to generate P0-Cre/WT, P0-Cre/R26-lacZ, P0-
Cre/ZEG, and P0-Cre/RFP mice. Meox2-Cre mice, which express Cre in
the epiblast from E5.5 (Tallquist and Soriano, 2000), were also bred
with R26-lacZ or Cre-reporter CAAG-lacZ mouse line (Sakai and Miya-
zaki, 1997). Wnt1-Cre mice (B6.Cg-Tg(Wnt1-cre)11Rth Tg(Wnt1-GAL4)
11Rth/J, Jackson Lab, Stock# 009107) were bred with C57BL/6 WT or
Cre-reporter mice R26-lacZ (Soriano, 1999) or R26-RFP to generate
Wnt1-Cre/WT or Wnt1-Cre/R26-lacZ or Wnt1-Cre/RFP. R26-lacZ
reporter mice were maintained on a mixed background of C57BL/6
(majority) and 129S6.
2.2 | Tissue collection
Timed pregnant mice were euthanized using CO2 followed by cervi-
cal dislocation to ensure death. The uterus with embryos was
removed and embryos were retrieved under a microscope. The tis-
sues were further dissected and processed for analysis, as described
below.
Embryos from P0-Cre mice were harvested at embryonic day (E)
8.0, E8.5, E9.5, and E10.5. Newborn P0-Cre/ZEG mice were harvested
immediately after birth. Meox2-Cre mouse embryos carrying a Cre-
reporter were obtained from E6.5 to E11.5. Wnt1-Cre mouse embryos
were collected at E8.0–E8.5. Noon of the day on which the dam was
positive for vaginal plug was designated as E0.5. The stages of these
embryos were confirmed by comparing the sizes and morphologies of
multiple organs. The number of pairs of somites was counted under a
microscope at the time of dissection.
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2.3 | Genotyping
Specific primers were used to genotype the mice. Primers A (50-CTC
GTG ATC TGC AAC TCC AGTC-30) and B (50-GAG ACT AGT GAG
ACG TGC TACT-30) were used to amplify fragments from the un-
recombined R26-lacZ reporter allele (550 bp). Primers A and C (50-
TGT GAG CGA GTA GTA ACA ACC-30) were used to detect the Cre-
recombined allele (680 bp). Primers E (50-CAG TCA GTT GCT CAA
TGT ACC-30) and F (50-ACT GGT GAA ACT CAC CCA-30) were used to
amplify fragments from the un-recombined CAAG-lacZ allele (450 bp),
whereas primers D (50-GTG CTG GTT ATT GTG CTG TCTC-30) and C
were used to detect Cre-dependent deletion of the floxed region
(680 bp). To detect a Cre transgene, Cre1 (50-GGA CAT GTT CGG
GAT CGC CAG GCG-30) and Cre2 (50-GCA TAA CCA GTG AAA CAG
CAT TGC TG-30) primers were used.
2.4 | X-gal staining
After dissection, the embryos were fixed with 4% paraformaldehyde
for 5 min at 48C, and washed three times with 0.1 M sodium phos-
phate buffer (PBS, pH 7.5), then stained with 1 mg mL21 of 5-bromo-
4-chloro-3-indolyl-beta-D-galactoside (X-gal, Sigma, Cat# B-4252) in
0.1 M PBS, 0.1% sodium deoxycholate, 0.2% Nonidet P-40, 2 mM
magnesium chloride, 5 mM potassium ferricyanide, and 5 mM potas-
sium ferrocyanide at 378C.
2.5 | Immunohistochemistry
Embryos were fixed with 4% paraformaldehyde in 0.1 M PBS (pH 7.3)
for 2 hr at 48C, rinsed in PBS and then infiltrated with 20–30% sucrose
prior to embedding in OCT/Tissue Tek (Sakura Finetek). Serial sections
were cut at 10-lm thickness. Sections were air dried, rehydrated and
blocked with 10% normal donkey serum for 1 hr at room temperature.
Primary antibodies against the following proteins were applied: Cre
recombinase (1:500, MAB3120, EMD Millipore, Billerica, MA), FOXA2
(1:500, 07-633, EMD Millipore, Billerica, MA), GFP (1:100, ab13970,
abcam, Cambridge, MA), p75 (1:200, sc-6188, Santa Cruz Biotechnol-
ogy, Dallas, TX), SOX9 (1:1000, sc-20095, Santa Cruz Biotechnology,
Dallas, TX; 1:1000, ab185966, abcam, Cambridge, MA). Primary anti-
bodies were diluted with 0.1 M PBS that contained 0.3% Triton X-100
and 1% normal donkey serum. After incubation with primary antibody
overnight at 48C, sections were washed three times with 0.1 M PBS,
and then incubated with secondary antibodies that were conjugated
with Alexa Fluor 488, Alexa Fluor 546 or 647 (1:500, Invitrogen) for 1
hr at room temperature in 0.1 M PBS containing 0.3% Triton X-100
and 1% normal donkey serum. Sections were counterstained with
DAPI solution for 5–10 min to visualize nuclei and were then rinsed in
PBS. After air drying, the slides were mounted with ProLong® Gold
antifade medium (Invitrogen, Eugene, OR), and the sections were
examined thoroughly using a light microscope (EVOS FL, Life Technol-
ogies). Colocalization of different immunosignals was confirmed and
photographed using a laser-scanning confocal microscope (Zeiss LSM
710).
To confirm the specificity of immunosignals, slides without the
addition of primary antibodies were used as negative staining controls
for all immunostainings in the present study. For determining specific-
ity of Cre immuno-labeling, Cre negative littermate embryos were sec-
tioned and immunoreacted with the same concentration of primary
and secondary antibodies. Additionally, Western blotting was con-
ducted using E9.5 P0-Cre embryos (Cre1 embryos and Cre- littermate
control) to further investigate the specificity of antibodies against Cre
recombinase (1:5000, MAB3120, EMD Millipore, Billerica, MA). A ubiq-
uitously expressed protein, IjB kinase complex associated protein
(IKAP) (1:5000, sc-8336, Santa Cruz Biotechnology) was used as a
loading control. Equal amounts of protein were used for electrophore-
sis in sodium dodecyl sulfate-polyacrylamide gel and transferred to a
nitrocellulose membrane. Procedures for blocking and antibody probing
were performed as described (Li et al., 2011). A single band at the
expected molecular weight was detected in a genotype-dependent
manner with the Cre antibody (Supporting Information Figure 1).
3 | RESULTS
3.1 | Meox2-cre driven R26-lacZ reporter expression
emerges earlier and is more consistent than CAAG-
lacZ
ROSA26 Cre reporter (hereafter, R26-lacZ) and CAAG-CAT-lacZ Cre
reporter (hereafter, CAAG-lacZ) mice have been widely used for cell
fate mapping. First, we compared the reporter sensitivity of these two
lines at early embryo stages (E6.5–E11.5, Figure 1) using the Meox2-
Cre transgenic line in which Cre activity emerges as early as E5.5 in the
epiblast (Tallquist and Soriano, 2000). In Meox2-Cre/R26-lacZ mice, X-
gal staining of whole embryos showed that signals appeared in the ear-
liest stage examined (E6.5) and that labeled cells were extensively dis-
tributed in the whole embryos throughout all the stages examined
(Figure 1a) similarly to the previous report (Tallquist and Soriano,
2000). In contrast, b-galactosidase (b-gal) activity in Meox2-Cre/CAAG-
lacZ embryos was not detected until E7.5 (n55 or more for each
stage). Weak signals were detected in the cardiac region at E8.5 (2/5)
and in the somites and heart region at E9.5 (2/5) (Figure 1b), but were
not apparent in head and other tissues in the trunk regions. At E10.5
and E11.5 (6/6 for each stage), the distribution of CAAG-lacZ expres-
sion in Meox2-Cre/CAAG-lacZ embryos was similar to that of Meox2-
Cre/R26-lacZ throughout the entire embryo (Figure 1b).
To examine whether the discrepancy between Meox2-Cre driven
R26-lacZ and CAAG-lacZ reporter activity was caused by DNA recombi-
nation efficiency, promoter silencing, or both, specific primers were
designed to detect unrecombined and recombined reporter alleles (Fig-
ure 1c,d). A fragment of 550 bp was produced using primers A and B
to detect the un-recombined R26-lacZ alleles. A Cre-recombined R26-
lacZ allele was detected using primers A and C, and the product was
approximately 680 bp (Figure 1c). For the CAAG-lacZ reporter system,
primers E and F were used to generate an 450 bp fragment from
unrecombined allele whereas primers D and C produced an 680 bp
fragment from the Cre-mediated allele (Figure 1d). Both Cre transgenes
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were detected using primers Cre1 and Cre2 to generate an 270 bp
fragment (Figure 1c,d).
In E8.5 Meox2-Cre/R26-lacZ embryos, the recombined allele was
reliably detected when both Cre and R26-lacZ transgenes were present
(Figure 1e, lane 1–3) compared to the absence of bands without Cre
transgene (Figure 1e, lane 4–7). In contrast, in Meox2-Cre/CAAG-lacZ
mice only half of the double transgenic embryos showed detectable
recombined allele at E8.5 (Figure 1f, E8.5, lane 1–2 vs. 4–5). The
FIGURE 1 (a,b): X-Gal visualization of the lacZ gene product b-galactosidase in R26-lacZ (a) and CAAG-lacZ (b) reporters driven by Meox2-
Cre at different mouse embryonic stages. b-gal positive signals (blue) were ubiquitous in R26-lacZ embryos at all stages examined from E6.5
to E11.5. In the CAAG-lacZ embryos, positive signals were not detected until E9.5 and the embryos were not ubiquitously labeled until
E10.5. At least two litters were dissected to collect 5 or more embryos at each stage. Scale bars in (b) also apply to (a). (c–f): Schematic dia-
grams (c,d) and representative genotyping data (e,f) of the R26-lacZ (c,e) and CAAG-lacZ (d,f) reporter systems. Meox2-Cre was used to drive
reporter gene activation. In the E8.5 Meox2-Cre/R26R-lacZ embryos, Cre recombined bands were consistently detected when both R26-lacZ
and Cre were present (e, lanes 1–3). However, recombined bands were detected in only 50% of the E8.5 Meox2-Cre/CAAG-lacZ embryos (f,
lane 1–2). Although both CAAG-lacZ and Cre were present, Cre recombination products were not detected in half of the E8.5 embryos (f,
E8.5, lane 4–5). At E9.5, the detection of Cre recombination products was coincident with the presence of both CAAG-lacZ and Cre (f, E9.5,
lane 5–7). n55 or more for each stage and genotype
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recombined allele was reliably detected at E9.5 (Figure 1f, E9.5, lane
5–7). These data suggest that Cre-dependent DNA recombination is
inconsistent in CAAG-lacZ early stage (E8.5) embryos.
3.2 | P0-Cre/R26-lacZ labels NC cells and derivatives
in early embryos
P0-Cre/CAAG-lacZ has been reported to label NC cells and derivatives
after E9.0 (Yamauchi et al., 1999). Because the R26-lacZ reporter is
more accessible to Cre-mediated DNA recombination than the CAAG-
lacZ described above, we used the R26-lacZ reporter to re-examine P0-
Cre transgene activity in early embryos at different somite stages using
X-gal staining in whole embryo tissue.
At the 4-somite stage (E8.5), signals emerged in the midline of the
neural groove region (Figure 2a,a’, arrows). In the 6-somite embryo
(E8.5) (Figure 2b,b’), b-gal positive signals were found in the forebrain,
hindbrain (arrows, Figure 2b’), first branchial arch and midline of the
trunk neural groove region (Figure 2b,b’). The staining pattern in the 9-
somite embryo was similar to that of the 6-somite stage but extended
more caudally and b-gal signals were obvious in the midline and otic
placodes (arrows, Figure 2c,c’). At the 12-somite (Figure 2d,d’), intense
staining was found in the hindbrain region, branchial arches, otic placo-
des (arrows, Figure 2d’), and optic eminences. In the trunk region, sig-
nals were apparent in the neural groove area and in lateral tissues
(Figure 2d,d’). At the 17-somite stage, positive signals were extensively
distributed in the embryo, adding more labeled tissue regions that
included the heart, frontonasal, and eye regions (Figure 2e). At the 22–
26 somite stages, b-gal positive signals were extensively distributed in
NC derivatives throughout the body, for example, frontonasal and eye
regions, branchial arches, heart, and dorsal root ganglia (Figure 2f,g).
FIGURE 2 Whole mount X-Gal visualization of the lacZ gene product b-galactosidase in P0-Cre/R26-lacZ mouse embryos at different
somite (s) stages (E8-E9, 4s-26s). The somite number is indicated in each panel. At the 4-somite stage, b-gal positive signals (blue) emerged
(a top, a’, arrows) in the midline ventral to the neural tube. At later stages, signals (arrows) extended to the forebrain (fb), hindbrain (hb),
and trunk regions of NC and NC derivatives. Signals were not obvious in the midbrain (mb) region. Cre negative control littermates (a, bot-
tom; b–g, right) were devoid of b-gal signal. Scale bars: 500 mm
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Notably, signals in the midbrain region were not apparent throughout
the examined stages (Figure 2a–g). In littermate control embryos, no
positive signals were observed within the embryos at the stages exam-
ined (Figure 2a–g).
3.3 | P0-Cre transgene expression is restricted to
migrating NC cells and notochord in early embryos
To analyze P0-Cre expression in cranial NC, we used a monoclonal anti-
body against Cre to examine Cre immunoreactivity at different early
somite stages of embryos. Specificity of Cre immunosignals were vali-
dated by three different methods: (1) Western blotting analysis to dem-
onstrate the presence of a single band of expected size in a genotype-
dependent manner (Supporting Information Figure 1), (2) immunohisto-
chemistry using Cre2 embryos labeled with primary antibody to show
no signals (Supporting Information Figure 2), and (3) immunohisto-
chemistry using Cre1 embryos without the primary antibody to deter-
mine background levels (Figures 3 and 4).
b-gal signals in the P0-Cre/R26-lacZ embryo emerged in the neural
groove region during the 4-somite stage (Figure 2a). We further identi-
fied the location and types of cells that express P0-Cre transgene
through investigating immunoreactivity for Cre recombinase and coloc-
alization with a NC cell marker SOX9 (Figure 3a,b) and a notochord
marker FOXA2 (Figure 3c) in serial sections of 4-somite embryos
(n57). Cre1 signals were seen in a cluster of cells ventrally adjacent to
the neural groove at the midbrain (Figure 3a, white arrowheads) and
hindbrain levels (Figure 3b,c, white arrowheads), which is consistent
with the P0-Cre/R26-lacZ whole mount staining for the reporter activ-
ity (Figure 2a). Cre immunosignals in clustered cells in the midline and
ventrally adjacent to floor plate colocalized with SOX9 (arrowheads,
Figure 3a,b) and FOXA2 (arrowheads, Figure 3c). However, Cre immu-
nosignals were not detected in SOX91 cells in the neural plate border
or mesoderm layer (arrows, Figure 3a,b) nor in the FOXA21 cells seen
in the floor plate (arrows, Figure 3c). Nonspecific immunosignals from
the secondary antibody were seen in the foregut diverticulum (dashed
outlines, Figure 3b,c), which were confirmed by staining while omitting
primary antibody (dashed outlines, Figure 3d).
At the 7–8 somite stage (n53), another NC marker p751 or/and
SOX91 cells were seen at all brain levels examined, that is, forebrain,
midbrain (Figure 4a), and hindbrain (Figure 4b). No Cre immunosignals
were seen in the midbrain (Figure 4a). In the hindbrain region Cre
immunosignals were detected in a small population of p751SOX91
cells in the mesodermal layer (arrows, Figure 4b), and in the mesen-
chyme of prospective branchial arch 1 (white arrowheads, Figure 4b).
Cre immunoreactivity was also apparent in FOXA21 cells in the noto-
chord region, that is, clustered cells ventrally adjacent to the floor plate
(white arrowheads, Figure 4d) but not in the FOXA21 cells seen in the
floor plate (arrows, Figure 4d). Again, nonspecific signals were seen in
the foregut diverticulum when using secondary antibody for Cre immu-
noreactions, which was confirmed by staining while omitting primary
antibody (white dashed outlines, Figure 4b,d,e).
In 14-somite embryos (n53), Cre1 cells were abundantly distributed
in the forebrain region and the immunosignals colocalized with SOX9 and
p75 (Figure 5a, arrowheads). Additionally, Cre signals were seen in some
of the SOX91p751 cells in the anterior hindbrain region (Figure 5a,
arrows). At the posterior hindbrain level (Figure 5b), an increasing inten-
sity gradient of Cre immunoreactivity was observed from the dorsal to
ventral region, that is, no immunosignals in the dorsal most part, faint
immunosignals in the trigeminal NC region (Figure 5b, tn), obvious immu-
nosignals in the branchial arch 1 region (Figure 5b, ba1), and intense
immunosignals in the optic eminence (Figure 5b, oe). Similarly, the pro-
portions of Cre1SOX91p751 cells relative to total SOX91 or/and p751
cells in different regions were different. In the dorsal most part, some
SOX91 cells in the neural fold region, presumably pre-migratory NC cells,
were observed and negative for Cre immunoreactivity (open arrowheads,
Figure 5c). In the trigeminal NC region, a subpopulation of SOX91p751
cells was Cre1 (white arrows, Figure 5c). In the primordium of branchial
arch 1, Cre immunosignals were apparent in a significant population of
SOX91p751 cells (arrows, Figure 5d). In the optic eminence most, if not
all, SOX91p751 cells were brightly labeled with Cre (white arrows, Figure
5e). Importantly, Cre1 cells were not seen in the Sox9- and p75- cells in
any tissue regions. In the negative control slides (Cre- embryo sections
with primary antibody staining and Cre1 embryo sections without pri-
mary antibody), no immunosignals were seen in the 14-somite embryo
tissue (Supporting Information Figure 2).
Compared to the 14-somite stage, 19-somite embryos (n54) had
a similar distribution pattern of Cre immunosignals, that is, an increas-
ing intensity gradient from the dorsal to ventral regions of the tissue
(Figure 6a,b). Additionally, increasing proportions of Cre1SOX91 cells
relative to the total number of SOX91 cells were observed from dorsal
to ventral regions (Figure 6c–e). However, the proportions of
Cre1SOX91 cells relative to total SOX91 cells in all regions were lower
than those at the 14-somite stage. At the anterior hindbrain level, Cre1
immunosignals were seen in some of the SOX91 cells in the hindbrain
and intense signals were distributed in the majority of SOX91 cells in
the forebrain (Figure 6a, arrows). At the posterior hindbrain level, Cre1
cells were seen in the trigeminal NC (Figure 6b,c, tn), branchial arch 1
(Figure 6b,d, ba1), and optic eminence (Figure 6b,e, oe). The intensity
of Cre immunosignals in the optic eminence was diverse in the SOX91
cells, some of which were negative for Cre (arrowheads, Figure 6e),
which is in contrast to almost all of SOX91 cells that showed presence
of Cre immunosignals in the 14-somite embryos (Figure 5e).
3.4 | P0-Cre labeled cells are distributed in cranial NC
and derivatives in early embryos and newborn mice
To confirm the specific labeling of P0-Cre/R26-lacZ and Cre immunosig-
nals, we used another Cre reporter line (R26-RFP) and found that the
distribution pattern of P0-Cre/R26-RFP signals (11s, Figure 7) was the
same as P0-Cre/R26-lacZ (Figure 2d, d’), that is, signals were found in
the hindbrain region, branchial arches, in the neural groove area and
lateral tissues in the trunk region (Figure 7a). Similar to lacZ expression
in P0-Cre/R26-lacZ embryos, RFP signals were not apparent in the mid-
brain region (mb). On tissue sections at the posterior hindbrain level,
Cre immunosignals and RFP signals largely colocalized (Figure 7b).
Again, an increasing gradient of Cre and RFP signal intensity and
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proportions of labeled cells was observed from the dorsal to ventral
region, that is, no signals in the dorsal-most part, faintly labeled cells
were sparsely found in the trigeminal NC region (Figure 7b, tn), obvi-
ously and frequent labeled cells (Cre1RFP1) in the branchial arch 1
region (Figure 7b, ba1), and intensely and mostly labeled in the optic
eminence (Figure 7b, oe). Auto-fluorescent blood cells and noncellular
FIGURE 3 Single-plane laser scanning confocal photomicrographs of transverse sections of a 4-somite P0-Cre embryo. Sections were
immunostained using an antibody against Cre (green) and were double labeled with SOX9 (purple, a,b) or FOXA2 (purple, c). Arrowheads
point to Cre immunoreactive cells co-labeled with SOX9 (a,b) or FOXA2 (c) in the notochord region. Arrows point to single labeled SOX91
cells in the NC cell region (a,b) and FOXA21 cells in the floor plate of neural tube (c). White dashed lines outline the foregut diverticulum
(b–d). In the negative control slide (d), primary antibodies were omitted. Scale bar: 50 lm for all images
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FIGURE 4 Immunoreactivity of Cre (green, a–d), SOX9 (purple, a–c) or FOXA2 (purple, d), and p75 (red, a–d) in transverse sections of a 7-
somite P0-Cre embryo at the midbrain (a) and hindbrain-forebrain (b–e) levels. Arrows in (c) point to some of the triple labeled
Cre1SOX91p751 cells in the NC cell region. Arrowheads in (d) point to Cre1 cells colabeled with FOXA2 in the notochord region and
arrows to FOXA21 cells in the floor plate of neural tube (d). White dashed lines outline the foregut diverticulum (b, d, and e). In the nega-
tive control slide (e), primary antibodies were omitted and only secondary antibodies were applied. Scale bar: 50 lm for all images (single-
plane laser scanning confocal)
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FIGURE 5 Photomicrographs of transverse sections of a P0-Cre embryo at the 14-somite stage. Sections were immunostained for Cre
(green), SOX9 (purple), and p75 (red) at the anterior hindbrain-forebrain level (a) and posterior hindbrain-forebrain level (b). (c–d) are higher
magnification images of trigeminal NC (c, tn), branchial arch 1 (d, ba1), and optic eminence (d, oe). Arrows (a) point to Cre1 cells that were
colabeled with SOX9 and p75 immunosignals in the anterior hindbrain regions, and arrowheads (a) point to triple labeled Cre1SOX91p751
cells in the forebrain regions. Open arrowheads (c) point to SOX91 cells in the neural fold region, presumably premigratory NC cells. Arrows
(c–e) point to Cre1 cells colabeled with SOX91 and p751, presumably migratory NC, in trigeminal NC regions (tn, c), first branchial arch 1
(ba1, d) and optic eminence (oe, e). Scale bars: 50 lm for all images (single-plane laser scanning confocal)
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FIGURE 6 Single-plane laser scanning confocal photomicrographs in transverse sections of a 19-somite P0-Cre embryo. Sections were
immunostained using an antibody against Cre (green) and were double labeled with SOX9 (purple, a–e). (c–d) are higher magnification
images of trigeminal NC (c, tn), branchial arch 1 (d, ba1), and optic eminence (d, oe). Arrows (a) point to Cre1 cells that were co-labeled
with SOX9 in the forebrain. Arrows (c–e) point to Cre1 cells co-labeled with SOX9 in trigeminal NC regions (tn, c), branchial arch 1 (ba1, d),
and optic eminence (oe, e). Arrowheads in e point to SOX91 cells without Cre immunosignals. Scale bars: 50 lm, also applies to other
images in the same panel
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FIGURE 7 Consistent distribution of Cre and RFP signals in P0-Cre/R26-RFP embryos with that in P0-Cre and P0-Cre/R26-lacZ embryos.
(a): Bright-field (top panel) and fluorescent (bottom panel) images of whole P0-Cre/R26-RFP embryos at 10–11 somite stages. The midbrain
(mb) region was devoid of RFP signals. Arrows point to the hindbrain region labeled with RFP. (b): Single-plane laser scanning confocal pho-
tomicrographs of a transverse section of an 11-somite P0-Cre(1)/R26-RFP(1) embryo at the hindbrain level. An increasing intensity gradient
of Cre and RFP signals from the dorsal to ventral region, that is, faint and sparse in the trigeminal NC (tn), clear and frequent in the bran-
chial arch 1 (ba1), bright and almost all in the optic eminence (oe). Arrowheads point to the autofluorescent blood cells. Arrows point to
some noncellular RFP1 fragments. (c): Confocal images of a transverse section of a 10-somite Cre2 embryo to illustrate the autofluorescent
blood cells and non-cellular RFP1 fragments (arrows). Scale bars: 200 lm in (a); 50 lm in (b and c)
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RFP1 fragments were also seen (Figure 7b, arrowheads) and confirmed
in the Cre2 tissue sections (Figure 7c, arrowheads).
To verify the specificity of P0-Cre in labeling NC cells and deriva-
tives, we examined whether P0-Cre faithfully labels the nasal and fron-
tal bones in the skull that are well-characterized cranial NC derivatives.
Consistent with a previous report using Wnt1-Cre mice (Jiang et al.,
2002), P0-Cre successfully labeled both nasal and frontal bones along
with dura mater (Figure 8a–c). Importantly, P0-Cre did not label the
parietal bones that are known as paraxial mesoderm derivatives (Figure
8c,d) (Chai and Maxson, 2006; Noden and Trainor, 2005). The fluores-
cent signals in the parietal bone region of whole mount tissue (Figure
8a) were confirmed on sections to be from the underlying meninges
(arrows, Figure 8d), which are NC derivatives (Jiang et al., 2002).
3.5 | Different distribution pattern ofWnt1-Cre
labeling from P0-Cre in cranial regions
In P0-Cre/R26-lacZ embryos (Figure 2), reporter labeling was not appa-
rent in the midbrain region. To further examine our observation, R26-
lacZ was crossed with Wnt1-Cre, which is well known for labeling
midbrain.
At the 6-somite stage (Figure 9a), the signals inWnt1-Cre/R26-lacZ
mouse embryos were intense in the midbrain and along the midline of
the neural groove (Figure 9a). In the 8-somite embryo (Figure 9b), b-gal
positive signals were extensively distributed in the midbrain (Figure
8b). However, signals in the hindbrain were absent at the 6-somite
stage (Figure 9b, arrows) and were sparse at the 8-somite stage (Figure
9b, arrows). At E10.5, the signals extended to the forebrain (fb), mid-
brain (mb), hindbrain (hb) and trunk regions of NC and NC derivatives
in Wnt1-Cre/R26-lacZ embryos (Figure 9c), for example, frontonasal
and eye regions, branchial arches, heart, and dorsal root ganglia. In con-
trast to the extensive labeling of Wnt1-Cre in the midbrain, P0-Cre
labeling in midbrain was not obvious (Figure 9c), which is consistent
with our earlier observations (Figure 2).
Next, we further analyzed the expression patterns of Wnt1-Cre
transgene in cranial NC using the antibody for Cre recombinase. In the
4-somite embryos (Figure 10a), Cre immunosignals were found in
SOX91 pre- and post-migratory NC cells and in the neural epithelium
at the midbrain level (Figure 10a). In contrast, SOX91 migrating NC
cells were negative for Cre in the hindbrain region (arrows, Figure 10b).
At the 7-somite stage (Figure 10c), Cre immunosignals were exten-
sively distributed in migrating NC cells in the midbrain and forebrain
regions, in addition to labeling of part of the neuroepithelium. Again, in
hindbrain regions, Cre immunosignals were observed only in the neural
fold and were not apparent in SOX91 migrating NC cells (arrows, Fig-
ure 10d). This is an interesting contrast to the abundant Cre immuno-
signals found in the hindbrain region of P0-Cre embryos at the 7-
somite stage (arrows, Figure 4b,c). At the presumptive notochord
regions, no Cre immunosignals were seen inWnt1-Cre embryos (arrow-
heads, Figure 10b,d). In the 16-somite embryos, Cre immunosignals
were found in the midbrain and forebrain but were not apparent in the
hindbrain (Figure 10e), which is in contrast to the distribution of Cre
immunosignals in the 16–19 somite P0-Cre embryos (Figures 5 and 6).
FIGURE 8 P0-Cre marks cranial NC and derived cells in the skull.
(a): GFP signals in the newborn P0-Cre1/ZEG1 (upper) and control
littermate (bottom) mice. (b): GFP signals on the coronal tissue
sections illustrate that the frontal bones (b,c), but not the parietal
bone (c,d), were labeled. (c) is the high magnification image of the
squared tissue region in (b). Abbreviations: AF, anterior frontal
suture; e, eye; F, frontal bone; N, nasal bone; P, parietal bone; PF,
posterior frontal suture; SS, sagittal suture. Scale bars: 500 mm in
(a), 200 mm in (b) and (d); 100 mm in (c)
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In the trigeminal NC regions (tn), first branchial arch 1 (ba1) and optic
eminence region (oe), Cre immunosignals were sparsely seen in migra-
tory NC cells (Figure 10f).
Also, R26-RFP Cre reporter was used to confirm the specific label-
ing of Wnt1-Cre driven R26-lacZ and Cre immunoreactivity. The distri-
bution pattern of signals in Wnt1-Cre/R26-RFP embryos (Figure 11a,
5–7s) was identical to that of Wnt1-Cre/R26-lacZ embryos (Figure 9a,b,
6–8s). The signals in Wnt1-Cre/R26-RFP mouse embryos were intense
in the midbrain (Figure 11a, arrowheads), and signals in the hindbrain
were not obvious at the 6- and 7-somite stages (Figure 11a, arrows).
On tissue sections of a 6-somite Wnt1-Cre/RFP embryo, the distribu-
tion of RFP1 cells was coincident with that of Cre1 cells (Figure 11b,c),
such as abundance within migrating NC cells in the midbrain and in the
forebrain neuroepithelium (Figure 11b). The labeling was sparse among
migrating NC cells in the hindbrain region (arrows, Figure 11c).
Taken together (Table 1 and Supporting Information Figure 3),
both P0-Cre and Wnt1-Cre label cranial NC cells, peaked at 7-somite
stage in Wnt1-Cre and 14-somite in P0-Cre. An overlap (in forebrain)
but distinct (Wnt1-Cre in midbrain and P0-Cre in hindbrain) distribution
patterns of the Cre activities were observed. In addition to NC, both
P0-Cre and Wnt1-Cre labeled other cells, for example, notochord was
labeled by P0-Cre and neuroepithelium byWnt1-Cre.
4 | DISCUSSION
The P0-Cre transgenic mouse line has been widely used for NC cell
fate mapping (Feltri et al., 1999b; Ono et al., 2015; Sommer and
Suter, 1998) and genetic modifications of NC-derived cells (Hu,
Strobl-Mazzulla, & Bronner, 2014; Liu and Xiao, 2011). However,
questions remain about how early, how specifically, and to what
extent P0-Cre transgene labels NC cells in early embryos. Moreover,
concerns about the specificity of P0-Cre and other Cre models in
labeling NC lineage have been raised (Trainor, 2005a,b). Therefore, a
detailed analysis of P0-Cre transgene activity is essential for the use
and data interpretation of this model. In the present study, we found
that the CAAG-CAT-Z (CAAG-lacZ) Cre reporter mice used in the
original report (Yamauchi et al., 1999) did not appropriately reflect
Cre activity in early stage embryos. We then investigated Cre activ-
ity using a R26-lacZ reporter and Cre immunoreactivity to find P0-
FIGURE 9 Whole mount X-Gal visualization of lacZ gene product b-galactosidase in Wnt1-Cre/R26-lacZ mouse embryos at different stages
(E8-E10.5). b-gal positive signals (blue) were extensive in the midbrain (mb) at the 6s (a) and 8s (b) stages, but were sparse in the hindbrain.
At later stages, signals extended to the forebrain (fb), midbrain (mb), hindbrain (hb) and trunk regions of NC and NC derivatives in Wnt1-
Cre/R26-lacZ tissue at E10.5 (c). In E9 P0-Cre/R26-lacZ mouse embryos (c), b-gal positive signals (blue) were found in the forebrain (fb),
hindbrain (hb) and trunk regions of NC and NC derivatives, but were not apparent in the midbrain (mb). Scar bars: 200 lm in (a and b);
1 mm in (c)
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FIGURE 10 Photomicrographs from sections of E8.5 Wnt1-Cre embryos at different somite stages immunostained for the Cre and NC cell
marker SOX9. At the 4–7 somite stages (a–d), Cre immunosignals (green) were bright in the midbrain (a, c) and derived NC cells and
colocalized with SOX9 (purple). In contrast, in the hindbrain-forebrain levels (b, d) Cre immunosignals were seen in SOX91 premigratory NC
cells but were absent in migrating NC cells. In 16-somite embryos (e, f), Cre immunosignals were seen in migrating NC cells in the midbrain
and forebrain regions (e). In the trigeminal NC regions (tn), first branchial arch 1 (ba1), and optic eminence region (oe), Cre immunosignals
were sparse in migratory NC cells. Scale bars: 50 mm (single-plane laser scanning confocal)
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Cre expression as early as the 4-somite stage in notochord labeled
with FOXA2 and in the migrating NC cells at the 7-somite stage
using the commonly used NC cell markers SOX9 (Mori-Akiyama,
Akiyama, Rowitch, & de Crombrugghe, 2003; Sahar, Longaker, &
Quarto, 2005; Spokony et al., 2002) and p75 (Young, 2000; Young,
Ciampoli, Hsuan, & Canty, 1999). Cre immunosignals were especially
extensive in the forebrain and hindbrain but not apparent in the
midbrain. Importantly, Cre immunosignals were not seen outside of
the NC cell population and notochord. Given the fact that noto-
chord derivatives are well-known to be restricted to the interverte-
bral disc (McCann, Tamplin, Rossant, & Seguin, 2012; Yamauchi
et al., 1999), our data demonstrated that P0-Cre can serve as a valu-
able tool for studies on NC cell lineage, especially for forebrain and
hindbrain NC derivatives. In contrast, Wnt1-Cre extensively labeled
pre- and post-migratory NC cells at the midbrain level, but only
sparsely in the trigeminal NC region at the hindbrain level. Addition-
ally, Wnt1-Cre labeled a large population of non-NC cells in the neu-
ral plate, which is consistent with previous reports (Echelard et al.,
1994; Rowitch et al., 1998).
4.1 | P0-Cre specifically labels a significant population
of, if not all, migrating NC cells and notochord
The specificity of Cre expression in the NC cell population was exam-
ined with two commonly used NC cell markers, p75 (Menendez, Yat-
skievych, Antin, & Dalton, 2011) to label migrating NC and SOX9
(Nakanishi, Chan, & Ito, 2007; Pomp, Brokhman, Ben-Dor, Reubinoff, &
Goldstein, 2005) to label both pre- and post-migratory NC cells. Our
data support the idea that P0-Cre specifically labels migrating NC cells
and notochord based on the following observations: (1) Cre immuno-
signals were only detected in p751SOX91 double labeled cells, and
were more intense in the NC cells that were close to their destinations;
(2) importantly, Cre immunosignals were not seen outside of the
p751SOX91 double labeled cells; (3) Cre immunosignals were not seen
FIGURE 11 Distribution of Cre and RFP signals in Wnt1-Cre/R26-RFP embryos. (a): Bright-field (top panel) and fluorescent (bottom panel)
images of whole Wnt1-Cre/R26-RFP embryos at 5–7 somite stages. In contrast to the P0-Cre/R26-RFP embryos, RFP signals were detected
in midbrain (mb) region (arrowheads), but not obvious in the hindbrain (hb, arrows). (b and c): Single-plane laser scanning confocal photomi-
crographs of a transverse section of a 6-somite Wnt1-Cre(1)/R26-RFP(1) embryo at the midbrain (b) and hindbrain (c) level. Arrows (c) point
to the trigeminal NC region that was devoid of RFP and Cre signals. Scale bars: 250 lm in (a); 50 lm in (b) and (c)
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in SOX91 cells in the neural fold region, which presumably premigra-
tory NC cells, and Cre immunosignals were rarely detectable in the
immediately delaminated NC cell region; and (4) Cre immunosignals
only colocalized with FOXA2 in the notochord region, and were absent
in FOXA21 cells in the floor plate. These data demonstrate that P0-Cre
is specific in labeling migrating NC cells and notochord. An increasing
gradient of intensity of Cre immunosignals and RFP signals was
observed from the dorsal to ventral regions suggesting that the expres-
sion of P0-Cre transgene in the NC cells is obtained during migration.
Our data are valuable in demonstrating the specificity of P0-Cre in
labeling NC cells in early embryos. The specificity of P0-Cre in labeling
cranial NC cells was further confirmed by the distribution of P0-Cre
labeled cells in the well-known NC derivatives in the skull, for example,
frontal bones and sutures, in contrast to the absence of labeled cells in
the parietal bone that is known to be non-NC derived.
The notochord is a rod-shaped structure in the midline that is ven-
trally adjacent to the neural tube (Jurand, 1974). Studies using a Cre
mouse line driven by the notochord-specific homeobox gene Noto that
traced the cell fate of notochord demonstrated that notochord serves
as a source of embryonic precursors of cells within the nucleus pulpo-
sus of the mature intervertebral disc (McCann et al., 2012). In our
study, P0-Cre transgene expression was detected in the notochord
region in the 4–7 somite stage embryos, which is consistent with a pre-
vious report demonstrating that P0-Cre transgene labels notochord in
addition to NC cells and derivatives (Yamauchi et al., 1999). With
exception to the labeling of notochord, P0-Cre labels migrating NC cells
specifically. Indeed, our data using P0-Cre to mark cranial bones, that is,
nasal and frontal but not parietal bone, further demonstrated the speci-
ficity of P0-Cre in labeling cranial NC derivatives and that P0-Cre mice
can be considered as a useful tool to trace NC lineages, at least cranial
NC-derived bones (Komatsu et al., 2013), during mouse embryonic
development.
However, P0-Cre did not label all of the NC cells in all of the tis-
sue regions. The proportions of Cre1 cells relative to the total num-
ber of p751SOX91 cells were different in different tissue regions.
NC cells migrate ventrally to their target tissue/organs and follow
certain paths after delamination. Thus, the increasing intensity
gradient of Cre immunosignals and RFP signals and increasing cell
proportions of Cre1 and RFP1 cells from dorsal to ventral regions
suggest that P0-Cre transgene expression emerged during NC migra-
tion. Although Cre immunosignals were not detected in all the
p751SOX91 cells, we cannot exclude the possibility that P0-Cre
does indeed label all NC cells. It would be difficult to evaluate the
exact proportion of P0-Cre transgene in labeling migrating NC cells
because the expression is transient and because P0-Cre can be
expressed in a NC cell for a short time frame at any time point. Our
observation that detection of Cre immunosignals in all the
p751SOX91 cells in the optic eminence and the majority of mesen-
chymal cells immediately under the epithelium of prospective bran-
chial arch 1 at the 14 somite stage supports the idea that P0-Cre
transgene is expressed in a significant population of, if not all,
migrating NC cells in the forebrain and hindbrain regions.
Several Cre reporter lines have been generated and are widely used
for cell fate mapping (Ikeya et al., 1997; Kawamoto et al., 2000; McMa-
hon et al., 1992; Novak et al., 2000;Weissman and Pan, 2015;Weissman
Sanes, Lichtman, & Livet, 2011). Among these reporter lines, ROSA26 and
CAAG are two commonly used promoters for driving reporter gene
expression (Araki, Araki, Miyazaki, & Vassalli, 1995; Kawamoto et al.,
2000). In the present study, the efficiency and reliability of two Cre
reporters, R26-lacZ and CAAG-lacZ, were compared using Mexo2-Cre, in
which Cre is expressed as early as E5.5 in epiblast (Tallquist and Soriano,
2000). We found that R26-lacZ reporter expression emerges earlier than
CAAG-lacZ reporter expression and that DNA recombination in R26-lacZ
was reliable and consistent with Cre expression. One interesting observa-
tion is that although all E9.5Meox2-Cre/CAAG-lacZ embryos showed evi-
dence of DNA recombination, the lacZ signals were weak, and were
restricted to the heart and somites. It is possible that the promoter activ-
ity to drive lacZ expression in the CAAG-lacZ cassette was silenced or
weaker than that of R26-lacZ in early stage embryos. Together, the data
suggest that less efficient and inconsistent DNA recombination, and
variable CAAG promotor activity might be the major reasons for this
discrepancy.
4.2 | P0-cre labels cranial NC cells in a cranial
region-specific manner
It has been reported that NC cells are generated by the 7-somite stage
at all levels of the forebrain, midbrain, and hindbrain (Chan and Tam,
1988; Nichols, 1981; Serbedzija, Bronner-Fraser, & Fraser, 1992). By
detecting both R26-lacZ reporter expression and Cre immunoreactivity
we found that P0-Cre transgene expression emerges at the 7-somite
stage in hindbrain and forebrain migratory NC cells. In the 14-somite
embryos, we found strong Cre immunosignals in a considerable subpo-
pulation of migrating NC cells labeled with SOX9 and p75 in the fore-
brain and hindbrain NC regions.
However, P0-Cre expression was rarely detected in the midbrain
region, which is in contrast to extensive distribution of Cre immunosig-
nals and RFP signals in the midbrain NC of Wnt1-Cre (Huang, Liu,
Huang, Zhao, & Cheng, 2010; Lewis et al., 2013). At E8.5, when cranial
NC cells emerge, Wnt1-Cre labels NC cells extensively in midbrain but
TABLE 1 Comparison between P0-Cre and Wnt1-Cre in labeling
cranial neural crest (NC), neural epithelium (NE), and notochord to
various extent
Cranial regions P0-Cre Wnt1-Cre
Forebrain NC 11 11
NE 2 11
Midbrain NC 2 11
NE 2 1
Hindbrain NC 11 6
NE 2 6
Notochord 1 2
11 extensively;1 clearly;6 rarely;2 negatively.
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many fewer cells were seen in hindbrain (Danielian, Muccino, Rowitch,
Michael, & McMahon, 1998; Echelard et al., 1994). Wnt1 and Wnt1-
Cre expression is not restricted to the NC domain but also labels dorsal
neural stem cells that contribute to both the central nervous system
and to neural progenitors (Barriga, Trainor, Bronner, & Mayor, 2015;
McMahon et al., 1992). In the present study, we crossed the same
R26-lacZ reporter mouse with P0-Cre and Wnt1-Cre and confirmed the
labeling pattern (Figure 9). The difference between P0-Cre and Wnt1-
Cre in labeling NC cells was profound in the midbrain and hindbrain,
which may be why P0-Cre and Wnt1-Cre label different populations of
cells in the orofacial organs, for example, tooth buds (Wang et al.,
2011) and taste buds (Boggs et al., 2016; Liu et al., 2012).
It has been reported that forebrain crest cells appear by the 8–14
somite stages and migrate dorsally over the presumptive eye where
they meet the ventrally migrating midbrain crest cells. Although we did
not see much Cre reporter activity or Cre immunoreactivity in the mid-
brain, Cre immunoreactivity was detected in all the SOX91p751 cells
in the optic eminence, which suggests that forebrain is the source of
NC cells that contribute to optic eminence development.
5 | CONCLUSIONS
The P0-Cre transgenic mouse model was first generated to label NC
derivatives (Yamauchi et al., 1999) and has been widely used for NC line-
age tracing (Boggs et al., 2016; Kawakami et al., 2011; Liu et al., 2012;
Ogawa et al., 2015; Wang et al., 2011) and genetic modification (Feltri
et al., 1999a; Komatsu et al., 2013; Nomura-Kitabayashi et al., 2009;
Ogawa et al., 2015). Differences have been found between P0-Cre and
Wnt1-Cre in labeling NC lineage. Here, we re-visited the P0-Cre model at
early embryonic stages and demonstrated that P0-Cre transgene specifi-
cally labels migrating cranial NC cells in the forebrain and hindbrain as
early as the 7-somite stage and reaches its peak expression at the 14-
somite stage. Additionally, P0-Cre labels notochord at the 4–7 somite
stages in early embryos. Moreover, the distribution pattern of P0-Cre
was different from Wnt1-Cre in labeling NC cells, especially in the mid-
brain and hindbrain regions. Our data indicate that the P0-Cre mouse
line is a valuable model for studies of NC and notochord lineage, and
that careful attention needs to be paid in choosing promoters to drive
Cre and its reporters for studies on NC lineage in early embryos.
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